MARY LOCKLEAR: Open Payments
NPI 1063171270 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$185 in 10 payments from 7 companies in 2025. Trend: 2023 $637 · 2024 $585 · 2025 $185
Food & beverage: $185
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $59 |
| Novo Nordisk Inc | 2 | $31 |
| PhotoniCare Inc | 1 | $23 |
| Abbott Laboratories | 1 | $22 |
| Lilly USA, LLC | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| PFIZER INC. | 1 | $15 |
Products named: TRELEGY ELLIPTA, OtoSight Middle Ear Scope, FREESTYLE LIBRE 3, MOUNJARO, Wegovy, GARDASIL 9, PREVNAR 20.
Industry payments across KY — which companies pay providers there.
